| Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy. | |
| | |
MedLine Citation:
|
PMID: 12071939 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Danazol has been used with success in some hematological diseases, but there is no report of this treatment in acute leukemia. We report here a case of remission of myelodysplastic syndrome with myelofibrosis in transformation after danazol therapy in a 72-yr-old man. The role of danazol in remission induction is briefly discussed. |
| | |
Authors:
|
G Damaj; F Lefrère; D Canioni; M T Rubio; I Radford-Weiss; F Valensi; B Varet; O Hermine |
Related Documents
:
|
1606529 - Clonal evolution in primary 5q-syndrome. 9190039 - Leukemia and/or myeloproliferative syndrome in neonates with down syndrome. 18805579 - Mutations of jak2 in acute lymphoblastic leukaemias associated with down's syndrome. 6986269 - The preleukemic syndromes (hematopoietic dysplasia) in childhood. 1172989 - Osteoarthritis beginning with inflammation. definitions and correlations. 1354979 - Anterograde amnesia in triazolam overdose despite flumazenil treatment: a case report. 3011649 - Length polymorphism in the pro alpha 2(i) collagen gene: an alternative explanation in ... 17220209 - Borate transporter slc4a11 mutations cause both harboyan syndrome and non-syndromic cor... 18518599 - Study of direct cp violation in b(+/-)-->j/psik(+/-)(pi(+/-)) decays. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: European journal of haematology Volume: 68 ISSN: 0902-4441 ISO Abbreviation: Eur. J. Haematol. Publication Date: 2002 Apr |
Date Detail:
|
Created Date: 2002-06-19 Completed Date: 2002-07-24 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 8703985 Medline TA: Eur J Haematol Country: Denmark |
Other Details:
|
Languages: eng Pagination: 233-5 Citation Subset: IM |
Affiliation:
|
Department of Clinical Hematology, Hôpital Necker Enfants-Malades, Paris, France. damajg@marseille.fnclcc.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Danazol / therapeutic use* Estrogen Antagonists / therapeutic use* Humans Male Myelodysplastic Syndromes / drug therapy*, pathology* Primary Myelofibrosis / drug therapy* Remission Induction |
| Chemical | |
Reg. No./Substance:
|
0/Estrogen Antagonists; 17230-88-5/Danazol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma.
Next Document: Mononucleosis syndrome and acute monocytic leukemia.